Stay updated with breaking news from Epic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX...
MarketsandResearch.biz has presented updated research on Global Lung Cancer Liquid Biops Market 2021 by Company, Regions, Type and Application, Forecast to 2026 that offers fine intelligence that prepares market players to compete well against their toughest competitors on the basis of growth, sales, and other vital...
7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequenci...
Additionally, it provides a futuristic perspective on various factors that are likely to boost the Global Molecular Biomarkers for Cancer Detection and Management Market growth in the years to come. Besides, authors of the report have shed light on the factors that may hamper the growth of the Global Molecular Biomarkers for Cancer Detection and Management Market. The report also helps in understanding the Global Molecular Biomarkers for Cancer Detection and Management Market through key segments including application, product type, and end user. This analysis is based on various parameter...
3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigen...